Could new US investment curbs complicate China’s biotech licensing surge?

行业与产业 · 医药与生命科学 · cn · 来源：South China Morning Post · 2026-10-26 08:00

Chinese biotech firms face fresh headwinds in their global expansion as Washington’s proposed outbound investment restrictions threaten to disrupt deal structures, even though drug

关键词：综合

原文链接：https://www.scmp.com/business/article/3372151/could-new-us-investment-curbs-complicate-chinas-biotech-licensing-surge

本页由情报雷达 INFO RADAR 采集整理，引用请注明来源「情报雷达 INFO RADAR」并附链接 https://intel.zovaxai.com/i/5afb2fc5d841479a。